{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:18:35Z","timestamp":1792124315390,"version":"4.4.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":295,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1111\/bjd.13110","type":"journal-article","created":{"date-parts":[[2014,5,11]],"date-time":"2014-05-11T09:02:12Z","timestamp":1399798932000},"page":"1493-1500","source":"Crossref","is-referenced-by-count":109,"title":["Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: a multicentre, retrospective study"],"prefix":"10.1093","volume":"171","author":[{"given":"Y.","family":"Fujisawa","sequence":"first","affiliation":[{"name":"Department of Dermatology; University of Tsukuba; 1-1-1 Tennodai Tsukuba Ibaraki 305-8575 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Tokyo Metropolitan Cancer and Infectious disease Center Komagome Hospital; Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kadono","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo; Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Miyagawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tokyo; Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tsukuba; 1-1-1 Tennodai Tsukuba Ibaraki 305-8575 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Tsukuba; 1-1-1 Tennodai Tsukuba Ibaraki 305-8575 Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,11,10]]},"reference":[{"key":"10.1111\/bjd.13110-BIB0001|bjd13110-cit-0001","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<2034::AID-CNCR21>3.0.CO;2-P","article-title":"Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face","volume":"86","author":"Fata","year":"1999","journal-title":"Cancer"},{"key":"10.1111\/bjd.13110-BIB0002|bjd13110-cit-0002","volume-title":"Malignant Vascular Tumors","author":"Weiss","year":"2008"},{"key":"10.1111\/bjd.13110-BIB0003|bjd13110-cit-0003","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/1097-0142(19811015)48:8<1907::AID-CNCR2820480832>3.0.CO;2-T","article-title":"Angiosarcoma of skin and soft tissue: a study of forty-four cases","volume":"48","author":"Maddox","year":"1981","journal-title":"Cancer"},{"key":"10.1111\/bjd.13110-BIB0004|bjd13110-cit-0004","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/1097-0142(19870301)59:5<1046::AID-CNCR2820590533>3.0.CO;2-6","article-title":"Angiosarcoma of the face and scalp, prognosis and treatment","volume":"59","author":"Holden","year":"1987","journal-title":"Cancer"},{"key":"10.1111\/bjd.13110-BIB0005|bjd13110-cit-0005","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1245\/s10434-013-3083-6","article-title":"Cutaneous angiosarcoma: a single-institution experience","volume":"20","author":"Perez","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/bjd.13110-BIB0006|bjd13110-cit-0006","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5227\/skincancer.24.350","article-title":"[Angiosarcoma: a report of 260 patients based on a study conducted by The Japanese Association of Dermatologic Surgery, and review of the literature]","volume":"24","author":"Mizukami","year":"2009","journal-title":"Skin Cancer"},{"key":"10.1111\/bjd.13110-BIB0007|bjd13110-cit-0007","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1002\/cncr.11667","article-title":"Cutaneous angiosarcoma of the scalp: a multidisciplinary approach","volume":"98","author":"Pawlik","year":"2003","journal-title":"Cancer"},{"key":"10.1111\/bjd.13110-BIB0008|bjd13110-cit-0008","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1155\/2000\/575781","article-title":"Confirmed angiosarcoma: prognostic factors and outcome in 50 prospectively followed patients","volume":"4","author":"Espat","year":"2000","journal-title":"Sarcoma"},{"key":"10.1111\/bjd.13110-BIB0009|bjd13110-cit-0009","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hed.21513","article-title":"Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp","volume":"33","author":"Guadagnolo","year":"2011","journal-title":"Head Neck"},{"key":"10.1111\/bjd.13110-BIB0010|bjd13110-cit-0010","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1245\/s10434-006-9335-y","article-title":"Treatment and outcome of 82 patients with angiosarcoma","volume":"14","author":"Abraham","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/bjd.13110-BIB0011|bjd13110-cit-0011","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/cncr.22822","article-title":"Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients","volume":"110","author":"Nagano","year":"2007","journal-title":"Cancer"},{"key":"10.1111\/bjd.13110-BIB0012|bjd13110-cit-0012","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3109\/09546634.2012.754839","article-title":"Comparison between taxane-based chemotherapy with conventional surgery-based therapy for cutaneous angiosarcoma: a single-center experience","volume":"25","author":"Fujisawa","year":"2014","journal-title":"J Dermatolog Treat"},{"key":"10.1111\/bjd.13110-BIB0013|bjd13110-cit-0013","doi-asserted-by":"crossref","first-page":"9552","DOI":"10.1073\/pnas.90.20.9552","article-title":"Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations","volume":"90","author":"Jordan","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/bjd.13110-BIB0014|bjd13110-cit-0014","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.10907","article-title":"Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)","volume":"104","author":"Grant","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1111\/bjd.13110-BIB0015|bjd13110-cit-0015","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1158\/0008-5472.CAN-04-2624","article-title":"Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells","volume":"65","author":"Pasquier","year":"2005","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.13110-BIB0016|bjd13110-cit-0016","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.1998.16.3.1112","article-title":"Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma","volume":"16","author":"Welles","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.13110-BIB0017|bjd13110-cit-0017","first-page":"115","article-title":"Concurrent radiotherapy and weekly paclitaxel for locally advanced or recurrent squamous cell carcinoma of the uterine cervix. A pilot study with intensification of dose","volume":"23","author":"Cerrotta","year":"2002","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1111\/bjd.13110-BIB0018|bjd13110-cit-0018","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/pros.20638","article-title":"Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway","volume":"67","author":"Zhang","year":"2007","journal-title":"Prostate"},{"key":"10.1111\/bjd.13110-BIB0019|bjd13110-cit-0019","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/095530099140078","article-title":"Radiobiological effects of docetaxel (Taxotere): a potential radiation sensitizer","volume":"75","author":"Creane","year":"1999","journal-title":"Int J Radiat Biol"},{"key":"10.1111\/bjd.13110-BIB0020|bjd13110-cit-0020","doi-asserted-by":"crossref","first-page":"20130439","DOI":"10.1259\/bjr.20130439","article-title":"Single institutional experience of the treatment of angiosarcoma of the face and scalp","volume":"86","author":"Miki","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1111\/bjd.13110-BIB0021|bjd13110-cit-0021","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1177\/030089160909500631","article-title":"Paclitaxel-dependent prolonged and persistent complete remission four years from first recurrence of secondary breast angiosarcoma","volume":"95","author":"Gambini","year":"2009","journal-title":"Tumori"},{"key":"10.1111\/bjd.13110-BIB0022|bjd13110-cit-0022","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijrobp.2008.06.1492","article-title":"Treatment of vascular soft tissue sarcomas with razoxane, vindesine, and radiation","volume":"74","author":"Rhomberg","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/bjd.13110-BIB0023|bjd13110-cit-0023","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jgo.2012.11.002","article-title":"Risk-adapted, dose escalation study of weekly docetaxel in the first-line treatment of elderly patients with advanced cancer","volume":"4","author":"Culine","year":"2013","journal-title":"J Geriatr Oncol"},{"key":"10.1111\/bjd.13110-BIB0024|bjd13110-cit-0024","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.1997.15.1.187","article-title":"Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer","volume":"15","author":"Fennelly","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.13110-BIB0025|bjd13110-cit-0025","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.jaad.2009.09.035","article-title":"Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy","volume":"63","author":"Fuller","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.13110-BIB0026|bjd13110-cit-0026","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.jaad.2013.08.055","article-title":"Angiosarcoma of the scalp successfully treated with pazopanib","volume":"70","author":"Tomita","year":"2014","journal-title":"J Am Acad Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13110","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13110\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:10:08Z","timestamp":1676365808000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/171\/6\/1493\/6616237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,10]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13110","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11,10]]}}}